MICALs are large (Ͼ1,000 aa), multidomain, cytosolic proteins expressed in specific neuronal and nonneuronal (thymus, lung, spleen, and testis) tissues both during development and in adulthood (4).From sequence analysis, it has been shown that MICALs contain two protein-protein interaction domains implicated in signal transduction and cytoskeletal organization, a calponin homology (CH) domain (7) and a LIM domain (8), plus a proline-rich region for Src homology 3 (SH3) domain recognition that mediates interaction with CasL, a multidomain docking protein localized at focal adhesions and stress fibers (4). Human MICAL-1 associates with the small GTPase Rab1 (6, 9) and with vimentin (4), a major component of intermediate filaments. In addition to the SH3 domainbinding motif, the C-terminal region (of Ϸ250 residues) contains coiled-coil motifs and binds the cytosolic domain of class A plexins (5). Thus, the MICALs are protein-binding scaffolds, but, uniquely, they combine this property with a highly conserved N-terminal region of some 500 residues, characterized by sequence analyses and functional studies as a putative flavoprotein monooxygenase (MO) required for semaphorin-plexin-mediated axon guidance (5).Flavoenzymes bind the cofactor FAD as an integral part of their structure. Despite Ͻ20% sequence identity between disparate members of this family, they share a similar fold and essentially identical FAD-binding sites (10). In contrast, the catalytic reactions carried out by the flavoenzymes are varied, and their active-site architectures differ accordingly. The structure of p-hydroxybenzoate hydroxylase (PHBH) provides the paradigm for the flavoprotein MO (hydroxylase) subset of flavoenzymes (11). Flavoprotein MOs act on a broad range of small molecules (e.g., phydroxybenzoate, steroids, and amino acids). The substrate(s), mode of action, and, indeed, function of the putative MO region in the MICALs are unknown.Our structural and biophysical analyses on the N-terminal portion of murine MICAL-1 confirm that this region has the architecture and characteristics of a flavoenzyme of the MO family, demonstrate the enzymatic activity to be NADPH-dependent, and reveal a mechanism for controlled substrate access to the active site, which is strongly indicative of large (potentially protein) substrates.
MethodsProtein Expression and Purification. The mMICAL 489 expression construct (amino acids 1-489 of the mouse MICAL-1 gene plus C-terminal His-tag) was generated by ligation-independent cloning (Gateway Technology, Invitrogen), overexpressed in Escherichia coli (DE3)pLysS (Novagen), and purified with Ni affinity and size-exclusion chromatography; all stages used the high-throughput pipeline of the Oxford Protein Production Facility (see Supporting Text, which is published as supporting information on the PNAS